Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Community news > Crick spinout to begin first-in-human clinical study for leukaemia

Crick spinout to begin first-in-human clinical study for leukaemia

GammaDelta Therapeutics has received Investigational New Drug approval from the US FDA for their GDX012 cell therapy to be investigated as a treatment for blood cancers. 
7 Jun 2021
United States of America
Community news

Featured

Clinicians

To view this News Article

Similar stories

Group leader, Steve West, has been awarded the Royal Society's prestigious Royal Medal for his research on DNA recombina… More...

After the CrickConnect Science Symposium in June, we caught up with one of the alumni speakers, Professor Gareth Inman, … More...

James Lovelock c. 1960. From Technology, Techniques, and Technicians at the NIMR c.1960–c.2000

Fellow NIMR alumni Jonathan Marsh describes the notable career of James Lovelock and his time at Mill Hill. James passed… More...

pupils from Schools in Mfuleni joined Ursula at the University of Cape Town Neuroscience Institute.

Ursula Rohlwink, a Crick African Network (CAN) fellow at the University of Cape Town, has secured a competitive Wellcome… More...

Have your say

 
This website is powered by
ToucanTech